World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: German Clinical Trials Register
Last refreshed on: 8 April 2024
Main ID:  DRKS00007590
Date of registration: 08/12/2014
Prospective Registration: Yes
Primary sponsor: Universitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Neurochirurgie
Public title: Intraocular pressure during neurosurgical procedures in context of the head position
Scientific title: Intraocular pressure during neurosurgical procedures in context of the head position
Date of first enrolment: 24/04/2015
Target sample size: 64
Recruitment status: Complete
URL:  http://drks.de/search/en/trial/DRKS00007590
Study type:  observational
Study design:  Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: basic science  
Phase: 
Countries of recruitment
Germany
Contacts
Name: Patrick    Czorlich
Address:  Martinistr. 52 20246 Hamburg Germany
Telephone: 040-7410-53750
Email: p.czorlich@uke.de
Affiliation:  Universitätsklinikum Hamburg-EppendorfKlinik und Poliklinik für Neurochirurgie
Name: Patrick    Czorlich
Address:  Martinistr. 52 20246 Hamburg Germany
Telephone: 040-7410-53750
Email: p.czorlich@uke.de
Affiliation:  Universitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Neurochirurgie
Key inclusion & exclusion criteria
Inclusion criteria: 1. Proof of pathology within in the fossa posterior with anterior-posterior head positioning or maximum turned head or spinal intradural procedures or spinal procedures without opening of the Dura mater in anterior-posterior positioning.

2. Written informed consent of the patient.

3. Expected compliance of the patient.


Exclusion criteria: 1. Evident or suspected pregnanct.
2. Visual disturbance of less than 0.05. Disturbance of eye motality due to pathology in the fossa posterior is no exclusion criteria.
3. Any ophthalmologic disease, especially any kind of glaucoma or astigmatism with more ± 8 dpt.
4. Any kind of known allergic reaction to local anaesthesia or mydriatic medication.
5. Known Diabetes melltius, peripheral vascular diseases or Body-Mass-Index >30.
6. Participation in any other interventional study.
7. Any diesease that interacts with this study.
8. Any other aspect that denies a participation in this study.
9. Any kind of emergency procedure with no time to considerate if the patient want to participate in this study.



Age minimum: 18 Years
Age maximum: None
Gender: All
Health Condition(s) or Problem(s) studied
Intraoperative intraocular pressure
Intervention(s)
Group 1: Spinal intradural procedures in prone position with anterior-posterior positioning of the head. In all patients pre- and postoperative ophthalmological examination will be performed. Beyond that pre-, intra- and postoperative intraocular pressure will be recorded.
Group 2: Fossa posterior procedures in prone position with anterior-posterior positioning of the head. In all patients pre- and postoperative ophthalmological examination will be performed. Beyond that pre-, intra- and postoperative intraocular pressure will be recorded.
Group 3: Fossa posterior procedures in semiprone position with maximum rotation of the head. In all patients pre- and postoperative ophthalmological examination will be performed. Beyond that pre-, intra- and postoperative intraocular pressure will be recorded.
Group 4: Controlgroup: Spine procedures in prone position with anterior-posterior positioning of the head and no loss of cerebrospinal fluid. In all patients pre- and postoperative ophthalmological examination will be performed. Beyond that pre-, intra- and postoperative intraocular pressure will be recorded.
Primary Outcome(s)
Measurement and description of the intraocular pressure, measured with a hand-held applanation tonometer (Tonopen XL), prior to intubation, after intubation, after final positioning for the procedure, after positioning every 30min until opening of the Dura mater, after losing of cerebrospinal fluid, every 30min to the end of the procedure, before returning to supine position and after extubation.
Secondary Outcome(s)
Complete ophthalmological examination one day prior to procedure and 5 to 7 days after the operation including measurement of intraocular pressure by tonometry after Goldman and visual testing.
Secondary ID(s)
Source(s) of Monetary Support
Universitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Neurochirurgie
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 21/10/2014
Contact:
ethik@aekhh.de
Ethik-Kommission der Ärztekammer Hamburg
+49-40-2022990
ethik@aekhh.de
Results
Results available:
Date Posted:
Date Completed: 12/10/2017
URL: http://drks.de/search/en/trial/DRKS00007590#studyResults
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history